Related medicinesSacubitrilCarperitide
Where it comes from
- Made in
- Muscle cells of the heart’s atria, where it waits in granules
- Sent out by
- Stretch of the atrial wall when blood volume or pressure rises
- Acts on
- Kidney
- Blood vessels
- Adrenal cortex
- Heart
What it does
- Makes the kidney pass more sodium and water
- Relaxes blood vessels, lowering the pressure the heart pumps against 1
- Dampens the renin-angiotensin-aldosterone system
In medicine
- Sacubitril, in Entresto, blocks neprilysin, the enzyme that destroys natriuretic peptides, to treat heart failure 2
- Carperitide, recombinant ANP, is used for acute heart failure in Japan
- A common NPPA variant, rs5065, lengthens ANP by two amino acids; it is one of the Peptide genes cards in the Evigenics report
Beyond the body’s own use
- ANP is hard to measure, so laboratories measure MR-proANP, a stable fragment of its precursor instead; in 1,641 patients with acute breathlessness it was non-inferior to BNP for diagnosing heart failure, at a threshold of 120 pmol/L 3
- Nesiritide, a recombinant form of the sister peptide BNP, was given for acute heart failure for a decade until a 7,141-patient trial found no effect on breathlessness or death; it is no longer marketed in the United States 4
- Medicine now works this system by stopping the peptides being destroyed rather than by giving them, because an infused natriuretic peptide lasts only minutes 2
- There is no grey market in ANP, and could not be: it is digested if swallowed and gone from the blood within minutes of an injection 1
Sources
- Potter et al., Natriuretic peptides, their receptors and cyclic GMP signalling, Endocrine Reviews 2006
- Sacubitril and valsartan (Entresto), FDA application NDA 207620
- Maisel et al., Mid-region pro-hormone markers in acute dyspnoea, Journal of the American College of Cardiology 2010
- O’Connor et al., Effect of nesiritide in acute decompensated heart failure, New England Journal of Medicine 2011
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.